ÂÜÀòÂÒÂ×

Catherine Larue is the CEO and Founder of Consulting In Biotechnology and Diagnostic (CoDx), established in October 2020, which focuses on integrating social philanthropy within its business model while providing strategic consulting in biotechnology and medical diagnostics. Since January 2018, Catherine has served as an Administrator at Fondation ARC pour la recherche sur le cancer, supporting oncology research initiatives. Catherine's extensive experience includes roles as an Independent Director on the Board of GENFIT and formerly at Quotient Limited, focusing on innovative diagnostics. Previous positions include Director of External Affairs and CEO at the Integrated BioBank of Luxembourg, where Catherine enhanced stakeholder engagement and managed biobanking services, as well as interim CEO at the Luxembourg Institute of Health. Catherine's background also includes leadership roles at Genfit and Bio-Rad Laboratories, with an early career at Sanofi. Educational credentials include a Ph.D. in Immunology and various executive management qualifications.